Boston, MA -- (SBWIRE) -- 05/04/2017 -- Bovine respiratory disease is a multifactorial and complex disorder caused due to a combination of more than one microbial pathogens, inadequate housing conditions, impaired host immunity, and environmental factors.

Technavio's analysts forecast the global bovine respiratory disease treatment to grow at a CAGR of 8.11% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global bovine respiratory disease treatment for 2017-2021. To calculate the market size, the report considers the include sales of branded drugs, generic drugs, and vaccines.

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Technavio's report, Global Bovine Respiratory Disease Treatment 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Get More Details on this Report and a Full Table of Contents at Global Bovine Respiratory Disease Treatment 2017-2021

Key vendors

-Bayer HealthCare
-Boehringer Ingelheim
-Elanco
-Merck
-Zoetis

Other prominent vendors

-Bimeda Group
-Ceva
-Huvepharma
-Inovio Pharmaceuticals
-Med-Pharmex
-Norbrook Laboratories
-Plumbline Life Sciences

Market driver

-Development of novel products
-For a full, detailed list, view our report

Market challenge

-High cost of therapies coupled with presence of natural alternatives
-For a full, detailed list, view our report

Market trend

-Growing focus on the development of combination drugs
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2021 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: Bayer HealthCare, Boehringer Ingelheim, Elanco, Merck, Zoetis, Bimeda, Ceva, Huvepharma, Inovio Pharmaceuticals, Med-Pharmex, Norbrook Laboratories, Plumbline Life Sciences

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:
-Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way
-Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H2, 2016
-Global Cardiovascular Disease Market to 2022 - Sanofi and Novartis to Become Market Leaders as Praluent and Entresto Drive Revenue Growth
-Severe Acute Respiratory Syndrome (SARS) Global Clinical Trials Review, H2, 2016
-Parkinson's Disease Global Clinical Trials Review, H2, 2016